Dr. Rupel Emmanuel Marshall Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 437 Brassie Ln, University Park, IL 60484 Phone: 630-936-6050 |
News Archive
"Employers could lose their ability to change health plans or negotiate better rates and benefits under new healthcare reform regulations, the top GOP staffer on the Ways and Means Committee's health panel said Wednesday. Dan Elling, the Republican staff director for the health subcommittee, raised the issue during a CQ-Roll Call policy forum."
A qualitative study by researchers at the University of Pittsburgh School of Medicine found that women in their 60s report various reasons behind why they lack libido.
ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD).
The University of Barcelona participates in the European project A-fit (Astronaut Exercise Prescriptions Promoting Health and Fitness on Earth), coordinated by the Karolinska Institute (Sweden). It aims at designing a fitness programme to avoid muscle atrophy associated to microgravity. Its results will contribute to the understanding of the beneficial effects of exercise in order to combat the effects of long-term muscle disuse. Findings may be also applied to other research areas, for instance, those diseases characterized by muscular dysfunction.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracic-length HeliFX Aortic Securement System.
› Verified 6 days ago